Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.

MLA

Stam, Ronald W., et al. “Association of High-Level MCL-1 Expression with in Vitro and in Vivo Prednisone Resistance in MLL-Rearranged Infant Acute Lymphoblastic Leukemia.” Blood, vol. 115, no. 5, Feb. 2010, pp. 1018–25. EBSCOhost, https://doi.org/10.1182/blood-2009-02-205963.

APA

Stam, R. W., Den Boer, M. L., Schneider, P., de Boer, J., Hagelstein, J., Valsecchi, M. G., de Lorenzo, P., Sallan, S. E., Brady, H. J. M., Armstrong, S. A., & Pieters, R. (2010). Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. Blood, 115(5), 1018–1025. https://doi.org/10.1182/blood-2009-02-205963

Chicago

Stam, Ronald W, Monique L Den Boer, Pauline Schneider, Jasper de Boer, Jill Hagelstein, Maria G Valsecchi, Paola de Lorenzo, et al. 2010. “Association of High-Level MCL-1 Expression with in Vitro and in Vivo Prednisone Resistance in MLL-Rearranged Infant Acute Lymphoblastic Leukemia.” Blood 115 (5): 1018–25. doi:10.1182/blood-2009-02-205963.